| 6.8 |
33.8 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 5.8 |
17.5 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 3.5 |
10.5 |
GO:0038095 |
positive regulation of mast cell cytokine production(GO:0032765) Fc-epsilon receptor signaling pathway(GO:0038095) |
| 3.4 |
17.2 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 3.4 |
3.4 |
GO:0003134 |
BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) |
| 3.1 |
18.7 |
GO:0010624 |
regulation of Schwann cell proliferation(GO:0010624) |
| 2.5 |
7.4 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 2.4 |
4.8 |
GO:0072197 |
ureter morphogenesis(GO:0072197) |
| 2.3 |
7.0 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 2.1 |
12.6 |
GO:0060718 |
chorionic trophoblast cell differentiation(GO:0060718) |
| 2.0 |
5.9 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
| 1.8 |
11.0 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 1.8 |
12.8 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 1.7 |
5.2 |
GO:0090403 |
oxidative stress-induced premature senescence(GO:0090403) |
| 1.6 |
16.3 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 1.5 |
4.6 |
GO:0090425 |
hepatocyte cell migration(GO:0002194) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
| 1.5 |
4.6 |
GO:1904049 |
regulation of spontaneous neurotransmitter secretion(GO:1904048) negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 1.5 |
4.6 |
GO:0003032 |
detection of oxygen(GO:0003032) |
| 1.4 |
7.2 |
GO:0060591 |
chondroblast differentiation(GO:0060591) |
| 1.4 |
4.2 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 1.3 |
4.0 |
GO:1904706 |
negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 1.3 |
6.4 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 1.3 |
3.8 |
GO:0097155 |
fasciculation of sensory neuron axon(GO:0097155) |
| 1.2 |
4.9 |
GO:0000255 |
allantoin metabolic process(GO:0000255) |
| 1.2 |
7.3 |
GO:0046880 |
regulation of follicle-stimulating hormone secretion(GO:0046880) follicle-stimulating hormone secretion(GO:0046884) |
| 1.1 |
6.9 |
GO:0060648 |
mammary gland bud morphogenesis(GO:0060648) |
| 1.1 |
4.6 |
GO:0021847 |
ventricular zone neuroblast division(GO:0021847) |
| 1.1 |
3.3 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 1.0 |
3.1 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 1.0 |
3.1 |
GO:0030210 |
heparin biosynthetic process(GO:0030210) |
| 1.0 |
4.1 |
GO:0071449 |
cellular response to lipid hydroperoxide(GO:0071449) |
| 1.0 |
5.8 |
GO:0042045 |
epithelial fluid transport(GO:0042045) |
| 0.9 |
2.8 |
GO:0008228 |
opsonization(GO:0008228) modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.9 |
4.7 |
GO:1900085 |
negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) |
| 0.9 |
2.7 |
GO:0019343 |
cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
| 0.9 |
1.8 |
GO:0035622 |
intrahepatic bile duct development(GO:0035622) |
| 0.9 |
7.9 |
GO:0060710 |
chorio-allantoic fusion(GO:0060710) |
| 0.9 |
8.7 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.9 |
13.9 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.9 |
2.6 |
GO:0035928 |
rRNA import into mitochondrion(GO:0035928) |
| 0.8 |
0.8 |
GO:0048389 |
intermediate mesoderm development(GO:0048389) pattern specification involved in mesonephros development(GO:0061227) anterior/posterior pattern specification involved in kidney development(GO:0072098) ureter urothelium development(GO:0072190) |
| 0.8 |
2.4 |
GO:1904177 |
regulation of adipose tissue development(GO:1904177) |
| 0.8 |
2.3 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.8 |
4.6 |
GO:0032346 |
positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
| 0.8 |
3.8 |
GO:0051365 |
cellular response to potassium ion starvation(GO:0051365) |
| 0.8 |
3.1 |
GO:1903181 |
regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
| 0.7 |
4.3 |
GO:0010528 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.7 |
1.4 |
GO:0014043 |
negative regulation of neuron maturation(GO:0014043) |
| 0.7 |
2.9 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.7 |
10.6 |
GO:0035994 |
response to muscle stretch(GO:0035994) |
| 0.7 |
2.1 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 0.7 |
0.7 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.7 |
1.4 |
GO:0048014 |
Tie signaling pathway(GO:0048014) |
| 0.7 |
1.4 |
GO:0072180 |
mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) mesonephric duct development(GO:0072177) mesonephric duct morphogenesis(GO:0072180) |
| 0.7 |
2.0 |
GO:0086046 |
membrane depolarization during SA node cell action potential(GO:0086046) |
| 0.7 |
2.6 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.7 |
5.2 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) |
| 0.6 |
1.9 |
GO:0035910 |
ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
| 0.6 |
0.6 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.6 |
2.4 |
GO:2000668 |
dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
| 0.6 |
2.3 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.6 |
1.7 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.6 |
1.2 |
GO:0099624 |
regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
| 0.5 |
3.3 |
GO:1902847 |
macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of tau-protein kinase activity(GO:1902949) |
| 0.5 |
1.6 |
GO:1902524 |
negative regulation of interferon-alpha production(GO:0032687) interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) negative regulation of interferon-beta biosynthetic process(GO:0045358) positive regulation of protein K48-linked ubiquitination(GO:1902524) |
| 0.5 |
2.2 |
GO:1990743 |
protein sialylation(GO:1990743) |
| 0.5 |
3.8 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.5 |
4.8 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.5 |
3.1 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.5 |
2.1 |
GO:0071051 |
polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.5 |
4.5 |
GO:0097421 |
liver regeneration(GO:0097421) |
| 0.5 |
2.4 |
GO:0032911 |
nerve growth factor production(GO:0032902) negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.5 |
1.9 |
GO:0060662 |
tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.5 |
1.4 |
GO:0060596 |
mammary placode formation(GO:0060596) |
| 0.5 |
0.9 |
GO:1901420 |
negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) negative regulation of response to alcohol(GO:1901420) |
| 0.5 |
3.7 |
GO:1901387 |
positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 0.5 |
1.4 |
GO:0042138 |
meiotic DNA double-strand break formation(GO:0042138) |
| 0.5 |
3.6 |
GO:0097460 |
ferrous iron import into cell(GO:0097460) |
| 0.4 |
1.3 |
GO:0036118 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.4 |
2.2 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.4 |
0.4 |
GO:0048859 |
formation of anatomical boundary(GO:0048859) |
| 0.4 |
1.3 |
GO:0048352 |
neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) |
| 0.4 |
2.1 |
GO:0050912 |
detection of chemical stimulus involved in sensory perception(GO:0050907) detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
| 0.4 |
0.4 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 0.4 |
1.2 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.4 |
1.2 |
GO:0003219 |
cardiac right ventricle formation(GO:0003219) |
| 0.4 |
1.2 |
GO:0046168 |
glycerol-3-phosphate catabolic process(GO:0046168) |
| 0.4 |
0.4 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) |
| 0.4 |
1.2 |
GO:0050975 |
sensory perception of touch(GO:0050975) |
| 0.4 |
1.6 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 0.4 |
1.1 |
GO:0001869 |
regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.4 |
0.7 |
GO:1903596 |
regulation of gap junction assembly(GO:1903596) |
| 0.4 |
1.1 |
GO:0060971 |
embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.4 |
1.8 |
GO:2001286 |
regulation of caveolin-mediated endocytosis(GO:2001286) |
| 0.4 |
3.2 |
GO:0043206 |
extracellular fibril organization(GO:0043206) |
| 0.4 |
0.4 |
GO:0060484 |
lung-associated mesenchyme development(GO:0060484) |
| 0.3 |
5.2 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) |
| 0.3 |
2.0 |
GO:0070100 |
negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 0.3 |
5.0 |
GO:2001275 |
positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
| 0.3 |
3.7 |
GO:2001014 |
regulation of skeletal muscle cell differentiation(GO:2001014) |
| 0.3 |
4.0 |
GO:2000465 |
regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.3 |
1.3 |
GO:0090336 |
positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.3 |
1.9 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.3 |
1.6 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.3 |
0.9 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 0.3 |
1.5 |
GO:1900170 |
negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 0.3 |
3.4 |
GO:0019243 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.3 |
1.2 |
GO:1901524 |
regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) |
| 0.3 |
0.6 |
GO:1903984 |
regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.3 |
1.8 |
GO:0042590 |
antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.3 |
1.2 |
GO:0032769 |
negative regulation of monooxygenase activity(GO:0032769) negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.3 |
1.2 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.3 |
2.4 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.3 |
0.9 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) |
| 0.3 |
2.6 |
GO:0002118 |
aggressive behavior(GO:0002118) |
| 0.3 |
1.4 |
GO:1904721 |
regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
| 0.3 |
2.8 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.3 |
0.8 |
GO:1902358 |
sulfate transmembrane transport(GO:1902358) |
| 0.3 |
1.4 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.3 |
7.8 |
GO:0010043 |
response to zinc ion(GO:0010043) |
| 0.3 |
0.8 |
GO:1903351 |
response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
| 0.3 |
0.5 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.3 |
2.7 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.3 |
7.7 |
GO:0010866 |
regulation of triglyceride biosynthetic process(GO:0010866) |
| 0.3 |
1.6 |
GO:0097369 |
sodium ion import(GO:0097369) |
| 0.3 |
0.8 |
GO:0035811 |
negative regulation of urine volume(GO:0035811) |
| 0.3 |
3.3 |
GO:1901898 |
negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.3 |
1.0 |
GO:0033030 |
negative regulation of neutrophil apoptotic process(GO:0033030) |
| 0.3 |
3.5 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.2 |
1.7 |
GO:0071699 |
olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 0.2 |
3.6 |
GO:0002495 |
antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
| 0.2 |
1.5 |
GO:0021631 |
optic nerve morphogenesis(GO:0021631) |
| 0.2 |
0.7 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.2 |
1.2 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.2 |
1.0 |
GO:1903026 |
negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.2 |
0.5 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.2 |
0.2 |
GO:0030397 |
membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
| 0.2 |
0.7 |
GO:0072092 |
ureteric bud invasion(GO:0072092) |
| 0.2 |
0.5 |
GO:0034372 |
very-low-density lipoprotein particle remodeling(GO:0034372) |
| 0.2 |
3.9 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 0.2 |
2.9 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.2 |
2.7 |
GO:0071257 |
cellular response to electrical stimulus(GO:0071257) |
| 0.2 |
1.1 |
GO:0071285 |
cellular response to lithium ion(GO:0071285) |
| 0.2 |
4.6 |
GO:0061298 |
retina vasculature development in camera-type eye(GO:0061298) |
| 0.2 |
3.1 |
GO:0072010 |
renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
| 0.2 |
0.4 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 0.2 |
0.6 |
GO:0051661 |
maintenance of centrosome location(GO:0051661) |
| 0.2 |
0.4 |
GO:0051593 |
response to folic acid(GO:0051593) |
| 0.2 |
0.6 |
GO:0060536 |
cartilage morphogenesis(GO:0060536) |
| 0.2 |
2.1 |
GO:0002043 |
blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.2 |
0.6 |
GO:0038145 |
macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.2 |
3.4 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.2 |
1.5 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.2 |
1.0 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.2 |
1.0 |
GO:2001170 |
negative regulation of ATP biosynthetic process(GO:2001170) |
| 0.2 |
1.2 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.2 |
0.6 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) regulation of nucleoside transport(GO:0032242) negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 0.2 |
0.6 |
GO:0002158 |
osteoclast proliferation(GO:0002158) |
| 0.2 |
0.6 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.2 |
0.4 |
GO:0035990 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.2 |
12.5 |
GO:1904893 |
negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.2 |
1.6 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.2 |
1.0 |
GO:0042699 |
follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.2 |
1.0 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.2 |
0.2 |
GO:1900127 |
positive regulation of hyaluronan biosynthetic process(GO:1900127) |
| 0.2 |
0.8 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.2 |
0.6 |
GO:1990481 |
mRNA pseudouridine synthesis(GO:1990481) |
| 0.2 |
0.6 |
GO:0097500 |
receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.2 |
0.6 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) Harderian gland development(GO:0070384) |
| 0.2 |
1.3 |
GO:0071467 |
cellular response to pH(GO:0071467) |
| 0.2 |
0.6 |
GO:0072531 |
pyrimidine-containing compound transmembrane transport(GO:0072531) |
| 0.2 |
3.5 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.2 |
2.5 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.2 |
1.8 |
GO:0071549 |
cellular response to dexamethasone stimulus(GO:0071549) |
| 0.2 |
1.8 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
| 0.2 |
1.2 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.2 |
0.3 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.2 |
3.6 |
GO:0051043 |
regulation of membrane protein ectodomain proteolysis(GO:0051043) positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.2 |
6.2 |
GO:0061003 |
positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.2 |
5.8 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.2 |
0.5 |
GO:0006592 |
ornithine biosynthetic process(GO:0006592) |
| 0.2 |
0.5 |
GO:1902260 |
negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
| 0.2 |
0.8 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.2 |
1.0 |
GO:1903847 |
regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
| 0.2 |
0.7 |
GO:0000393 |
spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.2 |
3.5 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) |
| 0.2 |
0.3 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.2 |
1.4 |
GO:0035898 |
parathyroid hormone secretion(GO:0035898) |
| 0.2 |
2.4 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.2 |
1.1 |
GO:0010820 |
positive regulation of T cell chemotaxis(GO:0010820) |
| 0.1 |
0.4 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.1 |
1.6 |
GO:0014883 |
transition between fast and slow fiber(GO:0014883) positive regulation of stem cell population maintenance(GO:1902459) |
| 0.1 |
1.8 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 |
0.7 |
GO:1902774 |
late endosome to lysosome transport(GO:1902774) |
| 0.1 |
2.9 |
GO:0016242 |
negative regulation of macroautophagy(GO:0016242) |
| 0.1 |
1.4 |
GO:0018126 |
protein hydroxylation(GO:0018126) |
| 0.1 |
0.4 |
GO:1902396 |
protein localization to bicellular tight junction(GO:1902396) |
| 0.1 |
0.4 |
GO:1902071 |
regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
| 0.1 |
1.2 |
GO:0016322 |
neuron remodeling(GO:0016322) |
| 0.1 |
1.1 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.1 |
0.9 |
GO:0045002 |
double-strand break repair via single-strand annealing(GO:0045002) |
| 0.1 |
1.7 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.1 |
0.7 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.1 |
3.2 |
GO:0046039 |
GTP metabolic process(GO:0046039) |
| 0.1 |
21.7 |
GO:0031032 |
actomyosin structure organization(GO:0031032) |
| 0.1 |
2.1 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.1 |
2.0 |
GO:0035020 |
regulation of Rac protein signal transduction(GO:0035020) |
| 0.1 |
0.4 |
GO:0045014 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.1 |
0.7 |
GO:0019336 |
phenol-containing compound catabolic process(GO:0019336) |
| 0.1 |
0.4 |
GO:2000409 |
positive regulation of T cell extravasation(GO:2000409) |
| 0.1 |
0.5 |
GO:0060266 |
positive regulation of respiratory burst involved in inflammatory response(GO:0060265) negative regulation of respiratory burst involved in inflammatory response(GO:0060266) negative regulation of respiratory burst(GO:0060268) |
| 0.1 |
5.2 |
GO:0035640 |
exploration behavior(GO:0035640) |
| 0.1 |
0.6 |
GO:0030836 |
positive regulation of actin filament depolymerization(GO:0030836) |
| 0.1 |
1.3 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.1 |
0.4 |
GO:0009153 |
purine deoxyribonucleotide biosynthetic process(GO:0009153) |
| 0.1 |
1.3 |
GO:2000653 |
regulation of genetic imprinting(GO:2000653) |
| 0.1 |
1.8 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.1 |
1.5 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.1 |
0.5 |
GO:2000211 |
regulation of glutamate metabolic process(GO:2000211) |
| 0.1 |
1.6 |
GO:0061001 |
regulation of dendritic spine morphogenesis(GO:0061001) |
| 0.1 |
0.6 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.1 |
3.3 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.1 |
0.6 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.1 |
0.4 |
GO:0046709 |
IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
| 0.1 |
0.4 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.1 |
1.0 |
GO:0007413 |
axonal fasciculation(GO:0007413) |
| 0.1 |
2.5 |
GO:0045026 |
plasma membrane fusion(GO:0045026) |
| 0.1 |
1.7 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.1 |
2.2 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.1 |
0.3 |
GO:0090069 |
regulation of ribosome biogenesis(GO:0090069) |
| 0.1 |
0.8 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.1 |
0.5 |
GO:0034379 |
very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.1 |
0.3 |
GO:0072356 |
chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.1 |
0.3 |
GO:0048819 |
positive regulation of keratinocyte proliferation(GO:0010838) regulation of hair follicle maturation(GO:0048819) regulation of catagen(GO:0051794) |
| 0.1 |
0.9 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 |
2.9 |
GO:0031365 |
N-terminal protein amino acid modification(GO:0031365) |
| 0.1 |
0.8 |
GO:0043116 |
negative regulation of vascular permeability(GO:0043116) |
| 0.1 |
1.8 |
GO:0090083 |
regulation of inclusion body assembly(GO:0090083) |
| 0.1 |
0.2 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.1 |
5.1 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.1 |
0.8 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.1 |
0.4 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.1 |
0.5 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
| 0.1 |
0.9 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 0.1 |
0.4 |
GO:1901475 |
pyruvate transmembrane transport(GO:1901475) |
| 0.1 |
1.5 |
GO:0006744 |
ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
| 0.1 |
1.0 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.1 |
6.6 |
GO:1903955 |
positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.1 |
2.4 |
GO:0071480 |
cellular response to gamma radiation(GO:0071480) |
| 0.1 |
3.3 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.1 |
0.5 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 0.1 |
0.8 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.1 |
0.5 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.1 |
0.1 |
GO:0071603 |
endothelial cell-cell adhesion(GO:0071603) |
| 0.1 |
0.3 |
GO:0044381 |
glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
| 0.1 |
0.6 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) asymmetric neuroblast division(GO:0055059) |
| 0.1 |
0.7 |
GO:0031274 |
regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 |
0.8 |
GO:1904153 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.1 |
1.0 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 |
0.6 |
GO:0014898 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.1 |
0.9 |
GO:0031998 |
regulation of fatty acid beta-oxidation(GO:0031998) |
| 0.1 |
0.7 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.1 |
1.4 |
GO:0001913 |
T cell mediated cytotoxicity(GO:0001913) |
| 0.1 |
2.6 |
GO:0051384 |
response to glucocorticoid(GO:0051384) |
| 0.1 |
0.2 |
GO:1900186 |
negative regulation of clathrin-mediated endocytosis(GO:1900186) regulation of synaptic vesicle endocytosis(GO:1900242) negative regulation of tumor necrosis factor secretion(GO:1904468) negative regulation of membrane invagination(GO:1905154) |
| 0.1 |
1.5 |
GO:1900026 |
positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
| 0.1 |
0.1 |
GO:0046098 |
guanine metabolic process(GO:0046098) |
| 0.1 |
1.4 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.1 |
0.1 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 0.1 |
0.6 |
GO:0008347 |
glial cell migration(GO:0008347) |
| 0.1 |
0.1 |
GO:1903347 |
negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.1 |
0.1 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 0.1 |
0.8 |
GO:1904321 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.1 |
1.1 |
GO:0098743 |
cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
| 0.1 |
0.7 |
GO:0006490 |
oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.1 |
1.3 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.1 |
0.4 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
| 0.1 |
0.9 |
GO:1901655 |
cellular response to ketone(GO:1901655) |
| 0.1 |
1.4 |
GO:0060351 |
cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
| 0.1 |
0.6 |
GO:0021542 |
dentate gyrus development(GO:0021542) |
| 0.1 |
1.1 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.1 |
1.7 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.1 |
0.4 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 0.1 |
0.3 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.1 |
0.4 |
GO:0031508 |
pericentric heterochromatin assembly(GO:0031508) |
| 0.1 |
0.2 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.1 |
1.6 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
| 0.1 |
0.1 |
GO:0090031 |
positive regulation of steroid hormone biosynthetic process(GO:0090031) |
| 0.1 |
0.4 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 0.1 |
3.1 |
GO:0035383 |
acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
| 0.1 |
0.9 |
GO:0015936 |
coenzyme A metabolic process(GO:0015936) |
| 0.1 |
0.2 |
GO:0045648 |
positive regulation of erythrocyte differentiation(GO:0045648) |
| 0.1 |
0.5 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
| 0.1 |
0.1 |
GO:0014041 |
regulation of neuron maturation(GO:0014041) |
| 0.1 |
0.2 |
GO:0021506 |
neural fold formation(GO:0001842) anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
| 0.1 |
0.3 |
GO:0000447 |
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.1 |
0.9 |
GO:0043277 |
apoptotic cell clearance(GO:0043277) |
| 0.1 |
0.6 |
GO:0044065 |
regulation of respiratory system process(GO:0044065) |
| 0.1 |
0.2 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) spindle midzone assembly(GO:0051255) mitotic spindle midzone assembly(GO:0051256) |
| 0.0 |
0.8 |
GO:0060259 |
regulation of feeding behavior(GO:0060259) |
| 0.0 |
1.5 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.0 |
1.8 |
GO:0033014 |
porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
| 0.0 |
0.2 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.0 |
0.3 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.0 |
0.2 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.0 |
0.1 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.0 |
0.1 |
GO:0019805 |
quinolinate biosynthetic process(GO:0019805) |
| 0.0 |
1.0 |
GO:0048009 |
insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.0 |
0.4 |
GO:0036065 |
fucosylation(GO:0036065) |
| 0.0 |
0.0 |
GO:0071500 |
cellular response to nitrosative stress(GO:0071500) |
| 0.0 |
0.1 |
GO:0007354 |
zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 0.0 |
0.1 |
GO:1901341 |
activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.0 |
0.3 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.0 |
0.5 |
GO:0046548 |
retinal rod cell development(GO:0046548) |
| 0.0 |
0.8 |
GO:0000132 |
establishment of mitotic spindle orientation(GO:0000132) |
| 0.0 |
0.8 |
GO:0000731 |
DNA synthesis involved in DNA repair(GO:0000731) |
| 0.0 |
0.3 |
GO:0097034 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.0 |
0.5 |
GO:0010388 |
protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
| 0.0 |
1.0 |
GO:0045773 |
positive regulation of axon extension(GO:0045773) |
| 0.0 |
0.2 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 0.0 |
0.7 |
GO:0072337 |
modified amino acid transport(GO:0072337) |
| 0.0 |
1.5 |
GO:0007631 |
feeding behavior(GO:0007631) |
| 0.0 |
0.3 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.0 |
0.2 |
GO:0043496 |
regulation of protein homodimerization activity(GO:0043496) |
| 0.0 |
0.1 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.0 |
0.2 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.0 |
0.5 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.0 |
1.4 |
GO:0006493 |
protein O-linked glycosylation(GO:0006493) |
| 0.0 |
0.2 |
GO:2000623 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.0 |
0.5 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.0 |
0.1 |
GO:0021886 |
hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
| 0.0 |
0.1 |
GO:2000628 |
regulation of miRNA metabolic process(GO:2000628) |
| 0.0 |
0.3 |
GO:0001516 |
prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
| 0.0 |
0.3 |
GO:1900087 |
positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
| 0.0 |
0.7 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.0 |
0.6 |
GO:0007566 |
embryo implantation(GO:0007566) |
| 0.0 |
0.7 |
GO:0030488 |
tRNA methylation(GO:0030488) |
| 0.0 |
0.2 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.0 |
0.5 |
GO:0035518 |
histone H2A monoubiquitination(GO:0035518) |
| 0.0 |
0.1 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) |
| 0.0 |
0.3 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.0 |
1.8 |
GO:0001889 |
liver development(GO:0001889) |
| 0.0 |
0.7 |
GO:0008542 |
visual learning(GO:0008542) |
| 0.0 |
0.0 |
GO:0032415 |
regulation of sodium:proton antiporter activity(GO:0032415) positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.0 |
0.9 |
GO:0030032 |
lamellipodium assembly(GO:0030032) |
| 0.0 |
0.4 |
GO:0045670 |
regulation of osteoclast differentiation(GO:0045670) |
| 0.0 |
0.8 |
GO:0006306 |
DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
| 0.0 |
0.1 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.0 |
1.2 |
GO:0010508 |
positive regulation of autophagy(GO:0010508) |
| 0.0 |
0.9 |
GO:0042073 |
intraciliary transport(GO:0042073) protein transport along microtubule(GO:0098840) |
| 0.0 |
0.2 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.0 |
0.4 |
GO:0043550 |
regulation of lipid kinase activity(GO:0043550) |
| 0.0 |
0.2 |
GO:0009649 |
photoperiodism(GO:0009648) entrainment of circadian clock(GO:0009649) entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.0 |
0.2 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.0 |
1.3 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 |
1.8 |
GO:0007030 |
Golgi organization(GO:0007030) |
| 0.0 |
1.2 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 |
0.1 |
GO:0050995 |
negative regulation of lipid catabolic process(GO:0050995) |
| 0.0 |
0.9 |
GO:0045740 |
positive regulation of DNA replication(GO:0045740) |
| 0.0 |
0.1 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 0.0 |
0.1 |
GO:0070200 |
establishment of protein localization to telomere(GO:0070200) |
| 0.0 |
0.1 |
GO:2000463 |
positive regulation of excitatory postsynaptic potential(GO:2000463) |
| 0.0 |
0.2 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.0 |
0.1 |
GO:0061087 |
positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.0 |
0.1 |
GO:0042993 |
positive regulation of transcription factor import into nucleus(GO:0042993) |
| 0.0 |
0.2 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.0 |
0.4 |
GO:0048286 |
lung alveolus development(GO:0048286) |
| 0.0 |
0.4 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.0 |
0.6 |
GO:0070206 |
protein trimerization(GO:0070206) |
| 0.0 |
0.6 |
GO:0007031 |
peroxisome organization(GO:0007031) |
| 0.0 |
0.2 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.0 |
0.5 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.0 |
0.4 |
GO:0051443 |
positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
| 0.0 |
0.1 |
GO:0048570 |
notochord morphogenesis(GO:0048570) |
| 0.0 |
0.1 |
GO:0010971 |
positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
| 0.0 |
0.1 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.0 |
0.2 |
GO:0006626 |
protein targeting to mitochondrion(GO:0006626) |
| 0.0 |
0.2 |
GO:0005978 |
glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.0 |
0.5 |
GO:2001238 |
positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.0 |
0.3 |
GO:0048538 |
thymus development(GO:0048538) |
| 0.0 |
1.1 |
GO:0007160 |
cell-matrix adhesion(GO:0007160) |
| 0.0 |
0.5 |
GO:0051017 |
actin filament bundle assembly(GO:0051017) |
| 0.0 |
0.1 |
GO:0000466 |
maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
| 0.0 |
0.1 |
GO:0006309 |
apoptotic DNA fragmentation(GO:0006309) |
| 0.0 |
0.1 |
GO:0090051 |
negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
| 0.0 |
0.3 |
GO:0007029 |
endoplasmic reticulum organization(GO:0007029) |
| 0.0 |
0.3 |
GO:0006888 |
ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.0 |
0.3 |
GO:0043001 |
Golgi to plasma membrane protein transport(GO:0043001) |
